Antibiotic resistance is widely recognized as one of the most urgent public health challenges of the twenty first century.

Sarepta has received US Food and Drug Administration (FDA) approval for updated prescribing information for Elevidys ...

Fred Hutch bioengineer Dr. Matthias Stephan is working to develop a special foam that could help make gene therapy for blood ...

Antibiotic resistance is widely recognized as one of the most urgent public health challenges of the twenty first century.

Around the globe, heart disease remains one of the top causes of death. Once patients begin to suffer from serious heart ...

Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.

MeiraGTx’s AAV-AIPL1 has already led to vision gains in blind children, as regulatory submissions for the gene therapy close ...

According to research by SNS Insider, the U.S. Preimplantation Genetic Testing Market will reach USD 528.43 million by 2032, driven by rising IVF cycle volumes, increased awareness of genetic ...

Climate change is driving drastic environmental shifts and accelerating global biodiversity loss. Hybrid introgression has ...

TSHA-102 granted Breakthrough Therapy designation by FDAFinalized FDA alignment on REVEAL pivotal trial protocol and SAP, including 6-month ...

The MarketWatch News Department was not involved in the creation of this content.-- Expanded Dyno Frontiers Program connects therapeutic developers to a marketplace of partners re ...

Taysha Gene Therapies (TSHA) stock has experienced significant price moves over the past few months, drawing renewed attention from investors. The company’s shares have surged more than 60% in the ...